Document is current
Any future updates will be listed below
-
Authors
Notario, Jaime https://orcid.org/0000-0001-9676-6147
Magdaleno-Tapial, Jorge
Rivera, Raquel
Riera-Monroig, Josep
Pujol, Conrad
Novella, Cynthia
Cuervas-Mons, Manuel
de la Cueva, Pablo
-
Funding
Funding for this research was provided by:
Janssen Cilag Spain
- License Information
-
More Information
Article History
Received: 31 May 2025
Accepted: 31 October 2025
First Online: 21 November 2025
Declarations
:
: Jaime Notario has perceived consultancy/speaker’s honoraria and/or participated in clinical trials sponsored by Abbvie, Almirall, Celgene, Gebro, IQVIA, Janssen, Leo Pharma, Lilly, MSD, Novartis and Pfizer. Jorge Magdaleno-Tapial has received consultancy/speaker’s honoraria and/or travel grants and/or participated in clinical trials sponsored by AbbVie, Almirall, Amgen, Boehringer Ingelheim, Celgene, Janssen, LEO Pharma, Lilly, Novartis, Sanofi and UCB. Raquel Rivera acted as a consultant and/or speaker for and/or participated in clinical trials sponsored by companies that manufacture drugs used for the treatment of psoriasis, including Abbvie, Almirall, Amgen, Boehringer, Bristol Myers Squibb, Janssen-Cilag, Leo Pharma, Lilly, Novartis, Pfizer and UCB. Josep Riera-Monroig has acted as a speaker and/or consultant for and/or participated in clinical trials from Almirall, Amgen, Abbvie, Novartis, Johnson & Johnson, UCB, LeoPharma, Pfizer, Eli Lilly, Boehringer, and Bristol Myers Squibb. Josep Riera-Monroig is an Editorial Board Member for Dermatology and Therapy . Josep Riera-Monroig was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Conrad Pujol has received grants and payments related to research, advice and training from Abbvie, Almirall, Amgen, Boehringer, Janssen-Cilag, Leo Pharma, Lilly, Novartis, Pfizer and UCB. Cynthia Novella and Manuel Cuervas-Mons are employees of Janssen. Pablo de la Cueva has received consultancy/speaker’s honoraria and/or travel grants and/or participated in clinical trials sponsored by Abbvie, Almirall, Amgen, BMS, Boehringer, Celgene, Johnson & Johnson, LEO Pharma, Lilly, MSD, Novartis, Pfizer, Roche, Sanofi, and UCB.
: The study protocol was approved by Ethics Committee of Hospital of Bellvitge, Barcelona (EPA028/20), on January 1, 2021. Patient consent waiver for this retrospective study was obtained from this Ethics Committee.
